Fresh allegations hit Lancet hydroxychloroquine study

The journal has since published an 'expressions of concern' declaration on the study

The row over a Lancet paper warning against hydroxychloroquine treatment for COVID-19 has flared again with new claims it relied on data from a company led by a surgeon named in three medical malpractice lawsuits.